PNPLA3 rs738409 Polymorphism Predicts Development and Severity of Hepatic Steatosis but Not Metabolic Syndrome in Celiac Disease.

MLA

Tortora, Raffaella, et al. “PNPLA3 Rs738409 Polymorphism Predicts Development and Severity of Hepatic Steatosis but Not Metabolic Syndrome in Celiac Disease.” Nutrients, vol. 10, no. 9, Sept. 2018. EBSCOhost, https://doi.org/10.3390/nu10091239.

APA

Tortora, R., Rispo, A., Alisi, A., Imperatore, N., Crudele, A., Ferretti, F., Nobili, V., Miele, L., Gerbino, N., Caporaso, N., & Morisco, F. (2018). PNPLA3 rs738409 Polymorphism Predicts Development and Severity of Hepatic Steatosis but Not Metabolic Syndrome in Celiac Disease. Nutrients, 10(9). https://doi.org/10.3390/nu10091239

Chicago

Tortora, Raffaella, Antonio Rispo, Anna Alisi, Nicola Imperatore, Annalisa Crudele, Francesca Ferretti, Valerio Nobili, et al. 2018. “PNPLA3 Rs738409 Polymorphism Predicts Development and Severity of Hepatic Steatosis but Not Metabolic Syndrome in Celiac Disease.” Nutrients 10 (9). doi:10.3390/nu10091239.